Neoadjuvant chemotherapy using low-dose consecutive intraarterial infusions of cisplatin combined with 5-fluorouracil for locally advanced cervical adenocarcinoma

Gynecologic Oncology

Volumn 81, Issue 3, 2001, Pages 496-499

  Aoki, Yoichi ^a   Sato, Takaaki ^a   Watanabe, Minoru ^a   Sasaki, Masaru ^a   Tsuneki, Ikunosuke ^a   Tanaka, Kenichi ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Cervical adenocarcinoma; Cisplatin and 5 fluorouracil; Low dose intraarterial infusion; Neoadjuvant chemotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; BONE MARROW TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG RESPONSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; TUMOR VOLUME; UTERINE CERVIX CARCINOMA;

EID: 0034980575     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6195     Document Type: Article

References (15)

1. Estimates of the worldwide incidence of eighteen major cancers in 1985
2. Stage Ib adenocarcinoma of the cervix: Metastatic potential and patterns of dissemination
3. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation
4. Neoadjuvant chemotherapy with mitomycin C, etoposide, and cisplatin for adenocarcinoma of the cervix
5. Adenocarcinoma of the uterine cervix
6. Prognostic factors of primary adenocarcinoma of the uterine cervix
7. Ovarian metastasis in stage IB and II cervical adenocarcinoma
8. Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: The final results
9. Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer
10. Intense neoadjuvant chemotherapy with cisplatin and epirubicin for advanced or bulky cervical and vaginal adenocarcinoma
11. Decrease in tumor volume and histologic response to intraarterial neoadjuvant chemotherapy in patients with cervical and endometrial adenocarcinoma
12. Combination of consecutive low-dose cisplatin with bleomycin, vincristine, and mitomycin for recurrent cervical carcinoma
13. Multidisciplinary, intra-arterial chemotherapy (IAC) with CDDP and 5-FU against cervical cancer
14. Combination chemotherapy for metastatic or recurrent adenocarcinoma of the cervix
15. Locally advanced cervical adenocarcinoma: Is there a place for chemo-surgical treatment?